The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Commercial Animal Cloning-Global Market Insights and Sales Trends 2025
Synopsis
Commercial animal cloning is the cloning of animals for commercial purposes. Currently, pets are being cloned commercially, along with livestock, competition camels and horses and even endangered and extinct animals.
The global Commercial Animal Cloning market size is expected to reach US$ 783.4 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Commercial Animal Cloning in various end use industries. The expanding demands from the Pets, Livestock and Others,, are propelling Commercial Animal Cloning market. Live Animal Cloning, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dead Animal Cloning segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 158%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Commercial Animal Cloning, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Commercial Animal Cloning market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Commercial Animal Cloning market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Commercial Animal Cloning sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Commercial Animal Cloning covered in this report include Sinogene, Sooam Biotech, ViaGen Pets, Boyalife and Trans Ova Genetics, etc.
The global Commercial Animal Cloning market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sinogene
Sooam Biotech
ViaGen Pets
Boyalife
Trans Ova Genetics
Global Commercial Animal Cloning market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Commercial Animal Cloning market, Segment by Type:
Live Animal Cloning
Dead Animal Cloning
Global Commercial Animal Cloning market, by Application
Pets
Livestock
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Commercial Animal Cloning companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Commercial animal cloning is the cloning of animals for commercial purposes. Currently, pets are being cloned commercially, along with livestock, competition camels and horses and even endangered and extinct animals.
The global Commercial Animal Cloning market size is expected to reach US$ 783.4 million by 2029, growing at a CAGR of 6.3% from 2023 to 2029. The market is mainly driven by the significant applications of Commercial Animal Cloning in various end use industries. The expanding demands from the Pets, Livestock and Others,, are propelling Commercial Animal Cloning market. Live Animal Cloning, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dead Animal Cloning segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 158%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Commercial Animal Cloning, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Commercial Animal Cloning market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Commercial Animal Cloning market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Commercial Animal Cloning sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Commercial Animal Cloning covered in this report include Sinogene, Sooam Biotech, ViaGen Pets, Boyalife and Trans Ova Genetics, etc.
The global Commercial Animal Cloning market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sinogene
Sooam Biotech
ViaGen Pets
Boyalife
Trans Ova Genetics
Global Commercial Animal Cloning market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Commercial Animal Cloning market, Segment by Type:
Live Animal Cloning
Dead Animal Cloning
Global Commercial Animal Cloning market, by Application
Pets
Livestock
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Commercial Animal Cloning companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Commercial Animal Cloning
1.1 Commercial Animal Cloning Market Overview
1.1.1 Commercial Animal Cloning Product Scope
1.1.2 Commercial Animal Cloning Market Status and Outlook
1.2 Global Commercial Animal Cloning Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Commercial Animal Cloning Market Size by Region (2018-2029)
1.4 Global Commercial Animal Cloning Historic Market Size by Region (2018-2023)
1.5 Global Commercial Animal Cloning Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Commercial Animal Cloning Market Size (2018-2029)
1.6.1 North America Commercial Animal Cloning Market Size (2018-2029)
1.6.2 Europe Commercial Animal Cloning Market Size (2018-2029)
1.6.3 Asia-Pacific Commercial Animal Cloning Market Size (2018-2029)
1.6.4 Latin America Commercial Animal Cloning Market Size (2018-2029)
1.6.5 Middle East & Africa Commercial Animal Cloning Market Size (2018-2029)
2 Commercial Animal Cloning Market by Type
2.1 Introduction
2.1.1 Live Animal Cloning
2.1.2 Dead Animal Cloning
2.2 Global Commercial Animal Cloning Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Commercial Animal Cloning Historic Market Size by Type (2018-2023)
2.2.2 Global Commercial Animal Cloning Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Commercial Animal Cloning Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Commercial Animal Cloning Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Commercial Animal Cloning Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Commercial Animal Cloning Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Commercial Animal Cloning Revenue Breakdown by Type (2018-2029)
3 Commercial Animal Cloning Market Overview by Application
3.1 Introduction
3.1.1 Pets
3.1.2 Livestock
3.1.3 Others
3.2 Global Commercial Animal Cloning Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Commercial Animal Cloning Historic Market Size by Application (2018-2023)
3.2.2 Global Commercial Animal Cloning Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Commercial Animal Cloning Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Commercial Animal Cloning Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Commercial Animal Cloning Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Commercial Animal Cloning Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Commercial Animal Cloning Revenue Breakdown by Application (2018-2029)
4 Commercial Animal Cloning Competition Analysis by Players
4.1 Global Commercial Animal Cloning Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Commercial Animal Cloning as of 2022)
4.3 Date of Key Players Enter into Commercial Animal Cloning Market
4.4 Global Top Players Commercial Animal Cloning Headquarters and Area Served
4.5 Key Players Commercial Animal Cloning Product Solution and Service
4.6 Competitive Status
4.6.1 Commercial Animal Cloning Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sinogene
5.1.1 Sinogene Profile
5.1.2 Sinogene Main Business
5.1.3 Sinogene Commercial Animal Cloning Products, Services and Solutions
5.1.4 Sinogene Commercial Animal Cloning Revenue (US$ Million) & (2018-2023)
5.1.5 Sinogene Recent Developments
5.2 Sooam Biotech
5.2.1 Sooam Biotech Profile
5.2.2 Sooam Biotech Main Business
5.2.3 Sooam Biotech Commercial Animal Cloning Products, Services and Solutions
5.2.4 Sooam Biotech Commercial Animal Cloning Revenue (US$ Million) & (2018-2023)
5.2.5 Sooam Biotech Recent Developments
5.3 ViaGen Pets
5.3.1 ViaGen Pets Profile
5.3.2 ViaGen Pets Main Business
5.3.3 ViaGen Pets Commercial Animal Cloning Products, Services and Solutions
5.3.4 ViaGen Pets Commercial Animal Cloning Revenue (US$ Million) & (2018-2023)
5.3.5 Boyalife Recent Developments
5.4 Boyalife
5.4.1 Boyalife Profile
5.4.2 Boyalife Main Business
5.4.3 Boyalife Commercial Animal Cloning Products, Services and Solutions
5.4.4 Boyalife Commercial Animal Cloning Revenue (US$ Million) & (2018-2023)
5.4.5 Boyalife Recent Developments
5.5 Trans Ova Genetics
5.5.1 Trans Ova Genetics Profile
5.5.2 Trans Ova Genetics Main Business
5.5.3 Trans Ova Genetics Commercial Animal Cloning Products, Services and Solutions
5.5.4 Trans Ova Genetics Commercial Animal Cloning Revenue (US$ Million) & (2018-2023)
5.5.5 Trans Ova Genetics Recent Developments
6 North America
6.1 North America Commercial Animal Cloning Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Commercial Animal Cloning Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Commercial Animal Cloning Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Commercial Animal Cloning Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Commercial Animal Cloning Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Commercial Animal Cloning Market Dynamics
11.1 Commercial Animal Cloning Industry Trends
11.2 Commercial Animal Cloning Market Drivers
11.3 Commercial Animal Cloning Market Challenges
11.4 Commercial Animal Cloning Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
